CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)

Clinical trials for CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) explained in plain language.

Never miss a new study

Get alerted when new CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) trials appear

Sign up with your email to follow new studies for CARCINOMA, NON-SMALL-CELL LUNG (NSCLC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New drug trial aims to shrink tumors before surgery

Disease control Not yet recruiting

This study is testing a new medicine called PF-08634404 for adults with early-stage or locally advanced non-small cell lung cancer. Researchers want to see if the drug works better when given alone or with chemotherapy, either before surgery or after other treatments. The trial w…

Matched conditions: CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)

Phase: PHASE2 • Sponsor: Pfizer • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

CARCINOMA, NON-SMALL-CELL LUNG (NSCLC)

Get alerted when new CARCINOMA, NON-SMALL-CELL LUNG (NSCLC) trials appear

New drug trial aims to shrink tumors before surgery